MABTAS 500MG

1
Mabtas 500mg - Anticancer drugs view uses, side
effects and price MHP

• MILLION HEALTH PHARMACEUTICALS

2
DESCRIPTION

• Mabtas 500mg is a anticancer medicine which
  prevents the growth and spread of cancer cells in
  the body. 
• Mabtas 500mg injection also indicated for the
  treatment of Non- Hodgkins lymphoma or chronic
  lymphocytic and with combination with another
  anticancer drugs like methotrexate is used for
  rheumatoid arthritis symptoms in adult
  treatment. 
• Mabtas 500mg with steroid regimen combination is
  given for the treatment of some rare disorders
  which cause blood vessels and other tissues
  inflammation in the body.

3
INDICATION

• Mabtas 500mg injection and hyaluronidase human
  injection are given alone or combination with
  another drugs to treat certain types of
  non-Hodgkin's lymphoma and chronic lymphocytic
  leukemia (cancer start in WBC). 
• Mabtas 500mg injection is also used with
  methotrexate (Otrexup, Rasuvo, Xatmep, others)
  for the treatment rheumatoid arthritis symptoms
  in adults that have been already treated with a
  some type of regimen known as tumor necrosis
  factor (TNF) inhibitor.
• Mabtas 500mg injection is a type in a
  classification of drugs called monoclonal
  antibodies. 

4
Chronic Lymphoma
5
PHARMACOKINETICS

• new type of "targeted" cancer treatment and an
  integral part of the body's immune system.
  Naturally the body build antibodies in along with
  to an antigen which has entered the body and
  attach to the antigen for destruction by the
  immune system. An essential cells only aimed by
  monoclonal antibiotics, they may leads to less
  toxicity to healthy cell and it is usually
  treatment recommended only for cancers in which
  antigens (and the respective antibodies) have
  been already identified. Mabtas works by linking
  to the CD20 antigen on normal and malignant
  B-cells. Hence the body's essential immune
  security are initiated to attack and kill the
  marked B-cells. Stem cells i.eyoung cells in the
  bone marrow which will grow into the various cell
  types and do not have the CD20 antigen. After
  treatment,CD20 antigen allows healthy B-cells to
  multiply

6
PRODUCT DETAILS

• Brand MabtasIngredients Rituximab Strength
  500mg Manufactured Intas pharmaceuticalsPack
  age injection

7
PHARMACOKINETICS

• ABSORPTIONNot availableDISTRIBUTIONvolume of
  distribution is 3.1 LMETABOLISMMaball 100mg
  metabolized by human antimurine antibody
  production.EXCRETIONnot available The half
  life of NHL is 22 days and for RA is 18.0 days,
  GPA and microscopic polyangitis is 23 days.

8
DOSAGE MANAGEMENT

• Mabtas is recommended to administer only through
  intravenous infusion not by IV push or bolus.
• ADMINISTRATION
• Take an Mabtas amount and diluted to final
  concentration of 1 mg/ml upto 4 mg/ml as infusion
  (containing either 0.9 Nacl or 5 dextrose in
  water). Invert gently the bag and mix the
  solution. Dispose unused drug left in vial.
• OVERDOSAGE If the patients had high dose
  of Mabtas 500mg
• then seek immediately to the emergency department
  or poison control help line. Please consult the
  doctor for further clarification.

9
DRUG INTERACTION

• Mabtas 500mg injection drug interaction has
  limited data is available at present.
• Combination with fludarabine or cyclophosphamide
  has no effects in pharmacokinetics in CLL
  patients. Combination with methotrexate had no
  effects in pharmacokinetics.

10
CONTRAINDICATIONS

• Hypersensitivity or murine proteins. Active
  severe infectons in rheumatoid arthritis
  Uncontrolled cardiac disease.

11
PREGNANCY

• CategoryC animal studies reproduction shown an
  adverse effect on the fetus. The drug has no
  sufficient and well controlled studies in humans,
  using in pregnant women benefits by warrant use
  of the drug.

12
LACTATION

• Mabtas 500mg excreted into human milk is unknown.
  Due to the drug belongs to large protein
  molecule, no information is available. Women
  should not breast feed during Mabtas 500mg
  injection treatment and 12 months following last
  dose.

13
STORAGE

• Store at 2C 3C Use the drug before expiry
  date Protected from direct sunlight Do not freeze
  or shake. Keep away from the childerns Discard
  the unused drug by asking the advice from doctor
  or pharmacist

14
MISSED DOSE

• If a dose missed to take at the time then have it
  suddenly before next dose timing, if time reach
  for next dose, then skip missed dose and continue
  and continue the regular schedule. Do not have 2
  dose at a same time.

15
CONTACT US

• EMAIL ID  millionhealthpharmaceuticals_at_gmail.com
  
• PHONE NO  91-9940472902
• WEBSITE URL  https//millionpharma.com/mabtas-500
  mg.php